Cross Staff Investments’s Bristol-Myers Squibb BMY Stock Holding History

Cross Staff Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$366K	Buy	6,350 +146	+2%	+$8.38K	0.21%	98
2026 Q1	$376K	Hold	6,204	–	–	0.19%	94
2025 Q4	$335K	Sell	6,204 -695	-10%	-$33.4K	0.18%	98
2025 Q3	$311K	Buy	6,899 +11	+0.2%	+$514	0.22%	105
2025 Q2	$319K	Sell	6,888 -90	-1%	-$4.42K	0.24%	99
2025 Q1	$426K	Buy	6,978 +8	+0.1%	+$466	0.32%	82
2024 Q4	$394K	Sell	6,970 -193	-3%	-$10.8K	0.27%	88
2024 Q3	$371K	Buy	7,163 +8	+0.1%	+$375	0.29%	91
2024 Q2	$297K	Buy	7,155 +9	+0.1%	+$403	0.25%	95
2024 Q1	$388K	Buy	7,146 +8	+0.1%	+$408	0.33%	86
2023 Q4	$366K	Buy	7,138 +7	+0.1%	+$367	0.32%	86
2023 Q3	$414K	Buy	7,131 +6	+0.1%	+$368	0.4%	71
2023 Q2	$456K	Buy	7,125 +5	+0.1%	+$335	0.42%	70
2023 Q1	$493K	Sell	7,120 -45	-0.6%	-$3.17K	0.49%	63
2022 Q4	$516K	Buy	7,165 +5	+0.1%	+$377	0.54%	59
2022 Q3	$509K	Buy	7,160 +4	+0.1%	+$290	0.57%	50
2022 Q2	$551K	Buy	7,156 +5	+0.1%	+$381	0.61%	50
2022 Q1	$522K	Buy	7,151 +6	+0.1%	+$403	0.48%	59
2021 Q4	$446K	Buy	+7,145	New	+$419K	0.4%	80

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Cross Staff Investments's BMY Position: Q2 2026 in Review

Cross Staff Investments increased its Bristol-Myers Squibb (BMY) stake by 2.4% in Q2 2026, buying an estimated $8.38K and bringing the position to 6,350 shares worth $366K. The position accounts for 0.21% of the portfolio, ranked #98.

Cross Staff Investments first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $551K in Q2 2022. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Cross Staff Investments held 6,350 shares of Bristol-Myers Squibb worth $366K as of Q2 2026.
Cross Staff Investments bought 146 Bristol-Myers Squibb shares in Q2 2026, an estimated $8.38K.
Bristol-Myers Squibb made up 0.21% of Cross Staff Investments's portfolio in Q2 2026, its #98 holding.
Cross Staff Investments first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
Cross Staff Investments's Bristol-Myers Squibb position peaked at $551K in Q2 2022.
878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Cross Staff Investments's 13F filing for Q2 2026, filed 22 Jul 2026.